| 臺北醫學大學 |
2006 |
Responses of neurons in trigeminal subnucleus caudalis to mustard oil injection into temporomandibular joint
|
蔡志孟; Tsai CM |
| 臺北醫學大學 |
2006 |
Inhibitory effect of botulinum neurotoxin on mustard oil-induced inflammation
|
蔡志孟; 鄧乃嘉; 李勝揚; Yang JC; Teng NC; Lee SY; Tsai CM |
| 臺北醫學大學 |
2006 |
Bond strength of light curing composite resin with various lights.In press.
|
鄧乃嘉; 李勝揚; 蔡志孟; Hwang SD; Teng NC; Tsai CM; Hwang HM; Wang WN; |
| 國家衛生研究院 |
2005-09 |
Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer
|
Chang, KT; Huang, CYF; Tsai, CM; Chiu, CH; Lok, YY |
| 國家衛生研究院 |
2005-09 |
IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells
|
Chang, KT; Tsai, CM; Chiou, YC; Chiu, CH; Jeng, KS; Huang, CYF |
| 國家衛生研究院 |
2005-07 |
Chemotherapy for non-small cell lung cancer in elderly patients
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2005-06 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Tsai, CM;Chiu, CH;Chou, TY;Li, LH;Hsiao, CY;Chen, M;Perng, RP;Tsai, SF |
| 國家衛生研究院 |
2005-06 |
A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy
|
Chen, YM;Perng, RP;Tsai, CM;Whang-Peng, J |
| 國家衛生研究院 |
2005-05-15 |
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
|
Chou, TY; Chiu, CH; Li, LH; Hsiao, CY; Tzen, CY; Chang, KT; Chen, YM; Perng, RP; Tsai, SF; Tsai, CM |
| 國家衛生研究院 |
2005-03 |
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 臺北醫學大學 |
2005 |
The effect of static magnetic field on lipopolysaccharide-induced cytotoxicity of fibroblast-an in vitro investigation
|
林哲堂;李勝揚; Huang HM; Lin CT; Chen YF; Tsai CM; Lo YJ; Lan WH; Lee SY |
| 臺北醫學大學 |
2005 |
Bond strength of light-cured composite resin using various light sources
|
黃豪銘; Hwang SD; Tsai CM; Teng NC; Huang HM; Lee SY; Wang WN |
| 臺北醫學大學 |
2005 |
Clinical syudy of a newly developed injection-type gingival retraction material
|
楊正昌; Yang JC; Tsai CM; Chen MS; Wei JY; Lee SY; Lin CT |
| 臺北醫學大學 |
2005 |
Evaluation of loading conditions on fatigue-failed dental implants by fracture surface analysis
|
黃豪銘; Huang HM; Tsai CM; Chang CC; Lin CT; Lee SY; |
| 臺北醫學大學 |
2005 |
The effect of static magnetic field on lipopolysaccharide-induced cytotoxicity of fibroblast-an in vitro investigation
|
黃豪銘; Huang HM; Lin CT; Chen YF; Tsai CM; Lo YJ; Lan WH; Lee SY |
| 國家衛生研究院 |
2004-07 |
Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
|
Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2004-07 |
Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy
|
Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J |
| 臺北醫學大學 |
2004 |
Animal study of newly developed injectable gingival reaction material
|
李勝揚; Yang JC; Weng CW; Chen CC; Tsai CM; Lee SY; |
| 臺北醫學大學 |
2004 |
Dynamic response analysis of the mechanism of mandible trauma.
|
黃豪銘; Lee LY; Huang HM; Huang JM; Chou SY; Lee SY; Chiu WT; Tsai CM; Lo YJ; Lin CT |
| 中國醫藥大學 |
2004 |
Effect of young barley leaf extract and adlay on plasma lipids and LDL oxidation in hyperlipidemic smokers
|
Yu, YM; Chang, WC; Liu, CS; Tsai, CM |
| 國家衛生研究院 |
2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy
|
Chen, YM; Perng, RP; Lee, CS; Lin, WC; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older
|
Chen, YM; Perng, RP; Chen, MC; Tsai, CM; Liu, JM; Whang-Peng, J |
| 中國醫藥大學 |
2003-05 |
LDL cholesterol and oxidation are significantly reduced in type 2 diabetic patients receiving a barley leaf essence supplemented olive oil diet
|
余雅美(Yu YM); (Tsai CM*)* |
| 國家衛生研究院 |
2003-02 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel
|
Chen, YM; Shih, JF; Lee, CS; Chen, MC; Lin, WC; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002-10 |
Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 中國醫藥大學 |
2002-02 |
Effect of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes
|
余雅美(Yu YM); 張文正(Chang WC); (Chang CZ); 謝慶良(Ching-Liang Hsieh); (*Tsai CM)* |
| 國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
| 中國醫藥大學 |
2001 |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
|
Hsu, NY; Ho, HC; Chow, KC; Lin, TY; Shih, CS; Wang, LS; Tsai, CM |
| 中國醫藥大學 |
2001 |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer
|
Hsu, NY; Ho, HC; Chow, KC; Lin, TY; Shih, CS; Wang, LS; Tsai, CM |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-01 |
Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: Interleukin-15 vs. interleukin-2
|
Chen, YM; Ting, CC; Peng, JW; Yang, WK; Yang, KY; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)
|
Chen, YM;Perng, RP;Peng, JW;Liu, TW;Yang, KY;Lin, WC;Wu, HW;Shih, JF;Liu, JM;Chen, LT;Tsai, CM |
| 國家衛生研究院 |
1997-05 |
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study
|
Perng, RP; Chen, YM; MingLiu, J; Tsai, CM; Lin, WC; Yang, KY; WhangPeng, J |
| 國家衛生研究院 |
1997-04 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer
|
Chen, YM;Wu, MF;Perng, RP;Chou, CM;Yang, KY;Lin, WC;Tsai, CM;Liu, JM;WhangPeng, J |
